In 2005, G8 leaders made a comd d mitment to "working with WHO, UNAIDS and other international bodies to develop and implement a package of HIV prevention, treatment and care, with the aim of coming as close as possible to universal access to treatment for all those who need it by 2010". 3 As the lead agency for the health sector response to HIV/AIDS, WHO has consulted widely with others to define its contribution, drawing on the "3 by 5" experience and the UNAIDS techd d nical support division of labour. 4 The following five strategic priorities will require a refocusing of WHO's efforts and the mobilization of new resources.
The first strategic direction recognizes that wider access to HIV testing and counselling is essential: data from recent surveys in heavily affected countries show that fewer than 10% of HIVdinfected persons know whether or not they are infected. 5 There has been a move towards offering HIV testing more routinely in health care settings, as well as a redevaluation of the intend d sity of predtest counselling. WHO will be consulting with partners to develop guidance on HIV testing in clinical setd d tings. Particularly lacking at the moment is guidance on the testing of children.
The second major priority is the delivery of prevention in health care settings. In particular, the requirements of people living with HIV and their families for prevention services have gone largely unaddressed. Also, the prevention of HIV transmission from HIVdinfected mothers to their children requires more attention. In developing countries, fewer than 10% of HIVdind d fected women are being reached with preventive interventions, 6 and prod d grammes are handicapped by the weakd d ness of maternal health care and the challenge of HIV transmission through prolonged breastfeeding. Measures to prevent HIV transmission in the healthd care setting are essential, as are partnerd d ships to ensure that preventiondrelated health services reach populations at high risk of contracting HIV, including drug users, sex workers and men who have sex with men. In addition to assembling the evidence base for emerging biomedid d cal preventive interventions such as male circumcision, WHO will guide impled d mentation of available measures.
Thirdly, achieving universal access requires not only continued efforts to scale up ART treatment, but also improved prevention and management of opportunistic infections, care (including nutrition and palliation) and a focus on treatment and care for neglected populations such as drug users and children.
WHO's fourth strategic direction calls for vigorous efforts to tackle health system challenges brought to light by the "3 by 5" initiative. These include inadequacies in human resources, labod d ratory and other infrastructure, systems to procure and supply drugs and other commodities, and overall administrative and management capacity. Unless these challenges are given priority, it will be difficult to ensure transition from the emergency mode of "3 by 5" to sustaind d able, longdterm programmes.
WHO's final priority will be the gathering, analysis, interpretation and dissemination of strategic information about the scalingdup of HIV/AIDS programmes in the health sector. Information concerning access to and coverage and impact of health sector interventions will be essential in order to assess progress towards universal access. Data will also need to include treatment outcomes such as rates of adherence to therapy, drug toxicity and patient survival, including HIVdfree survival for infants of infected mothers.
The WHO response to HIV/AIDS over the next five years comprises an evidencedbased health sector approach that emphasizes prevention, treatment and care at the same time as reinforcing health systems. Universal access cannot be a mere slogan. The task ahead is helpd d ing WHO Member States to provide quality HIV/AIDS services to everyone who needs them. O References Web version only, available at: http://www. who.int/bulletin
